Thalidomide and celecoxib as potential modulators of irinotecan’s activity in cancer patients

Author: Villalona-Calero Miguel   Schaaf Larry   Phillips Gary   Otterson Gregory   Panico Kevin   Duan Wenrui   Kleiber Barbara   Shah Manisha   Young Donn   Wu Wan-Hong   Kuhn John  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.59, Iss.1, 2007-01, pp. : 23-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content